Leukotriene antagonists

Results: 44



#Item
21Oregon Health Resources Commission

Oregon Health Resources Commission

Add to Reading List

Source URL: www.oregon.gov

Language: English - Date: 2014-07-15 14:00:36
22HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. ®

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-07-18 15:46:49
23Untitled Document  This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It

Untitled Document This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-06-24 11:44:58
24Accolate (zafirlukast) tablets label

Accolate (zafirlukast) tablets label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-08-09 13:45:35
25Accolate (zafirlukast) tablets

Accolate (zafirlukast) tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-07-19 14:56:04
26[removed]SINGULAIR® (MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES DESCRIPTION

[removed]SINGULAIR® (MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:08:39
27HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-29 14:25:21
28Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended  SINGULAIR

Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended SINGULAIR

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2013-07-31 09:27:32
29Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended  Montelukast+Mometasone

Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Montelukast+Mometasone

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2013-10-30 11:06:38
30EU PSUR Work Sharing Summary Assessment Report Accolate - Zafirlukast IE/H/PSUR[removed]P-RMS

EU PSUR Work Sharing Summary Assessment Report Accolate - Zafirlukast IE/H/PSUR[removed]P-RMS

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-05-06 06:23:41